The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Insights into the main subtypes of PTCL
In this video, Francisco Vega, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, briefly highlights the importance of gene expression profiling studies in peripheral T-cell lymphoma (PTCL). Prof. Vega shares some insights into the biology underlying the two major subtypes of PTCL, as well as the importance of better understanding these. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
F.V. receives research funding from NCI, CRISP Therapeutics, Allogene, and Geron corporation There are no other competing financial interests to declare.
